Literature DB >> 15273881

[Spanish version of the 7 Minute screening neurocognitive battery. Normative data of an elderly population sample over 70].

T del Ser Quijano1, F Sánchez Sánchez, M J García de Yébenes, A Otero Puime, M V Zunzunegui, D G Muñoz.   

Abstract

INTRODUCTION: To standardize the Spanish version of the 7 Minute screening neurocognitive battery (7MS) in a population sample of elderly over 70 years.
METHODS: We examined 416 persons, living at home, participating in elderly the longitudinal study "Aging in Leganes", aged 71 to 99 years old (mean age: 79 +- 9.2 years; 51.7 % women; 10.6 illiterate, 25 % without formal education). In order to do so, we used an extensive clinical survey, general and neurological exam and extensive neuropsychological battery with several cognitive scales, attention, language, memory, visuomotor skill and reasoning tests, Jorm's IQCODE questionnaire, CES-D depression questionnaire and the 7MS including the Benton Orientation Test, Clock Drawing Test, Free and Cued Learning Test and Categorial Verbal Fluency. Dementia was diagnosed according to DSM-IV criteria but independently of the 7MS scores. Several methods to obtain the total score of the 7MS were analyzed and the normative parameters of the test were obtained in the subgroup of non-demented subjects.
RESULTS: The easiest and most efficient method to obtain the total score of the 7MS was the sum of the z-scores of the four subtests. We present the mean values, -1 and -1.5 standard deviations, range and percentiles of the partial and total scores of the 7MS stratified by age (71-75, 76-80, 81-85 and > or = 86 years) and education (less than primary education and primary education or greater) in the subgroup of non-demented subjects.
CONCLUSIONS: The normative data of the 7MS obtained in a representative sample of the general elderly population support its rigorous use in the Spanish clinical setting.

Entities:  

Mesh:

Year:  2004        PMID: 15273881

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  19 in total

1.  Normative data of a brief neuropsychological battery for Spanish individuals older than 49.

Authors:  Montserrat Alegret; Ana Espinosa; Georgina Vinyes-Junqué; Sergi Valero; Isabel Hernández; Lluís Tárraga; James T Becker; Mercè Boada
Journal:  J Clin Exp Neuropsychol       Date:  2011-12-13       Impact factor: 2.475

2.  Paradoxical recovery in a bilingual patient with aphasia after right capsuloputaminal infarction.

Authors:  A García-Caballero; I García-Lado; J González-Hermida; R Area; M J Recimil; O Juncos Rabadán; S Lamas; G Ozaita; F J Jorge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

3.  Global Performance of Executive Function Is Predictor of Risk of Frailty and Disability in Older Adults.

Authors:  C Rosado-Artalejo; J A Carnicero; J Losa-Reyna; C Castillo; B Cobos-Antoranz; A Alfaro-Acha; L Rodríguez-Mañas; F J García-García
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

4.  Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Montserrat Alegret; Georgina Vinyes-Junqué; Mercè Boada; Pablo Martínez-Lage; Gemma Cuberas; Ana Espinosa; Isabel Roca; Isabel Hernández; Sergi Valero; Maitée Rosende-Roca; Ana Mauleón; James T Becker And; Lluís Tárraga
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort.

Authors:  Adelina Orellana; Pablo García-González; Sergi Valero; Laura Montrreal; Itziar de Rojas; Isabel Hernández; Maitee Rosende-Roca; Liliana Vargas; Juan Pablo Tartari; Ester Esteban-De Antonio; Urszula Bojaryn; Leire Narvaiza; Emilio Alarcón-Martín; Montserrat Alegret; Daniel Alcolea; Alberto Lleó; Lluís Tárraga; Vanesa Pytel; Amanda Cano; Marta Marquié; Mercè Boada; Agustín Ruiz
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

6.  From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery.

Authors:  Montserrat Alegret; Ana Espinosa; Gemma Ortega; Alba Pérez-Cordón; Ángela Sanabria; Isabel Hernández; Marta Marquié; Maitée Rosende-Roca; Ana Mauleón; Carla Abdelnour; Liliana Vargas; Ester Esteban de Antonio; Rogelio López-Cuevas; Juan Pablo Tartari; Emilio Alarcón-Martín; Lluís Tárraga; Agustín Ruiz; Mercè Boada; Sergi Valero
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

7.  Design, methods and demographic findings of the DEMINVALL survey: a population-based study of Dementia in Valladolid, Northwestern Spain.

Authors:  Miguel Angel Tola-Arribas; María José Garea; María Isabel Yugueros; Fernando Ortega-Valín; Ana Cerón; Beatriz Fernández-Malvido; Marta González-Touya; Antonio San José; Ana Botrán; Vanessa Iglesias; Bárbara Díaz-Gómez
Journal:  BMC Neurol       Date:  2012-08-30       Impact factor: 2.474

8.  eVITAL: a preliminary taxonomy and electronic toolkit of health-related habits and lifestyle.

Authors:  Luis Salvador-Carulla; Carolyn Olson Walsh; Federico Alonso; Rafael Gómez; Carlos de Teresa; José Ricardo Cabo-Soler; Antonio Cano; Mencía Ruiz
Journal:  ScientificWorldJournal       Date:  2012-04-01

9.  Detection of mild cognitive impairment in people older than 65 years of age and its relationship to cardiovascular risk factors (DECRIVAM).

Authors:  M Victoria Perea-Bartolome; Ricardo García-García; Valentina Ladera-Fernández; Sara Mora-Simón; María C Patino-Alonso; Tita J Almanza-Guerra; Cristina Agudo-Conde; M Paz Muriel-Diez; Emiliano Rodríguez-Sánchez
Journal:  BMC Public Health       Date:  2011-06-27       Impact factor: 3.295

10.  Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study.

Authors:  Emiliano Rodríguez-Sánchez; Sara Mora-Simón; María C Patino-Alonso; Ricardo García-García; Alfonso Escribano-Hernández; Luis García-Ortiz; Ma Victoria Perea-Bartolomé; Manuel A Gómez-Marcos
Journal:  BMC Neurol       Date:  2011-11-17       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.